PuSH - Publikationsserver des Helmholtz Zentrums München: TGF-β signalling in COPD: Deciphering genetic and cellular susceptibilities for future therapeutic regimen.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Königshoff, M. ; Kneidinger, N.* ; Eickelberg, O.

TGF-β signalling in COPD: Deciphering genetic and cellular susceptibilities for future therapeutic regimen.

Swiss Med. Wkly. 139, 554-563 (2009)

Verlagsversion Volltext

PMC

	Free journal

Abstract
Metriken
Zusatzinfos

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in the developed world and associated with a high individual and socioeconomic burden. Despite emerging preventive efforts and ongoing clinical trials, the frequency and mortality of COPD are expected to continue to rise over the next decades. COPD is defined as an irreversible expiratory airflow limitation, which is caused by various degrees of the following two main features: First, small airway disease (SAD), which includes airway inflammation and remodelling, and second, emphysema, which is characterised by airspace enlargement. The major risk factor for COPD is cigarette smoke exposure; however, the molecular mechanisms linking smoke to different COPD features on the cellular level remain elusive. The transforming growth factor (TGF)-β superfamily constitutes more than 40 members, which are essential during organ development, a process often recapitulated in chronic diseases. Emerging interest in the role of TGF-β in the pathogenesis of COPD has recently evolved, particularly since genetic studies have demonstrated an association of gene polymorphisms of the TGF-β superfamily with COPD. In addition, increased expression of TGF-β1 in COPD lungs and primary cells, such as epithelial cells, macrophages, or fibroblasts isolated from COPD specimens, was reported, suggesting an impact of TGF-β signalling on the development and progression of COPD. Thus, targeted interventions of TGF-β signalling may represent a suitable therapeutic option in COPD. In this review, we will summarise the current understanding of the impact of TGF-β in COPD pathogenesis. The review is separated into five chapters: 1) an introduction to COPD, 2) an introduction to TGF-β signalling, 3) a summary of TGF-β gene polymorphisms in COPD, 4) a summary of TGF-β signalling in small airway disease, and 5) a summary of TGF-β signalling in emphysema.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Altmetric

1.436

0.730